European CVMP Adopts Vet Drug MRL Opinion on Ciclesonide
March 5, 2019

On February 22, Europe's Committee for Medicinal Products for Veterinary Use (CVMP) published an adopted opinion recommending the amendment of MRLs for ciclesonide in Equidae.

Based on the CVMP opinion, the European Commission will adopt a legally binding Regulation establishing the MRLs for the substance. Applicants may request re-examination of any CVMP opinion within 15 days of its publication.

The proposed MRLs from the summary opinion will display in the Global MRL Database on March 6, 2019.

All News Tags